Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fetal Mesencephalic Dopamine Neuronal Precursor Cells in Parkinson's Disease
NCT01860794Phase 2Unknown
- Sponsor
- Cambridge Health Alliance
- Start
- May 2013
- Primary completion
- Apr 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of fetal mesencephalic dopamine neuronal precursor cells in Parkinson's disease (PD), sponsored by Cambridge Health Alliance. Status: unknown.
02
Drugs
fetal mesencephalic dopamine neuronal precursor cells
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01860794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860794.